Weaning and extubation

Surgical approach (if applicable)

  • Not a surgical operation. Relevant procedural/ICU workflow:
    • Daily sedation hold / spontaneous awakening trial (SAT) + spontaneous breathing trial (SBT)
    • Assess readiness, plan extubation strategy (standard vs high-risk), prepare equipment and staff
    • Extubate to appropriate support (face mask, HFNO, NIV, CPAP), monitor closely, manage complications
    • If failure: treat reversible causes, re-intubate early if needed; consider tracheostomy if prolonged wean

Anaesthetic management (if applicable)

  • Context: ICU weaning/extubation or end-of-anaesthetic extubation (the principles overlap).
  • Type of anaesthesia:
    • ICU: sedation/analgesia titration rather than intra-op anaesthesia
    • Theatre: GA with ETT/SGA; extubation at end of case
  • Airway device:
    • Consider airway exchange catheter for high-risk extubation; consider staged extubation
  • Duration:
    • ICU: days–weeks; theatre: minutes at end of surgery
  • How painful:
    • Inadequate analgesia → tachypnoea, poor cough, splinting, atelectasis, extubation failure
  • Key anaesthetic/ICU priorities:

Definitions and aims

  • Weaning: gradual reduction of ventilatory support until patient sustains adequate spontaneous ventilation.
  • Extubation: removal of ETT when airway protection and ventilation/oxygenation are adequate.
  • Aims: minimise ventilator-associated harm (VAP, diaphragm dysfunction, delirium) while avoiding premature extubation and re-intubation.

Physiology relevant to weaning

  • Work of breathing increases when support is reduced: resistive (airway resistance, secretions, bronchospasm) + elastic (↓ compliance: oedema, atelectasis, ARDS) loads.
  • Cardiovascular: transition to spontaneous breathing increases venous return and LV afterload (more negative intrathoracic pressure) → may precipitate pulmonary oedema/ischaemia in vulnerable patients.
  • Respiratory muscle function: diaphragm disuse atrophy with controlled ventilation; fatigue if load exceeds capacity during SBT.
  • Gas exchange: loss of PEEP/mean airway pressure can worsen V/Q mismatch and atelectasis; oxygenation may drop post-extubation.

Readiness to wean: prerequisites (ICU)

  • Underlying cause improving and no new major instability.
  • Oxygenation acceptable on modest settings.
    • Target SpO2 typically 92–96% (or 88–92% in COPD/CO2 retainers as appropriate).
  • Ventilation adequate: pH acceptable (often ≥ 7.30) with manageable PaCO2 for that patient.
  • Haemodynamic stability: minimal/no vasopressors, no uncontrolled arrhythmia/ischaemia.
  • Neurological: awake enough to initiate breaths and protect airway; delirium/agitation controlled.
  • Temperature, Hb, electrolytes: treat fever, anaemia, hypophosphataemia, hypomagnesaemia, hypokalaemia which impair muscle function.
  • Airway/secretions: manageable secretions, effective cough, suctioning not excessively frequent.

Weaning strategies (ICU)

  • Daily protocolised approach: SAT + SBT reduces duration of ventilation and ICU stay.
  • SBT methods: T-piece, CPAP, or low-level pressure support (e.g., PS 5–8 cmH2O with PEEP 5).
    • Duration often 30–120 minutes depending on unit protocol and patient risk.
  • Gradual reduction: reduce PS, reduce SIMV rate (less favoured), or switch to assisted modes; avoid prolonged SIMV-only weans if not progressing.
  • Adjuncts: physiotherapy, early mobilisation, optimise nutrition, treat fluid overload, bronchodilators, diuresis if weaning-induced pulmonary oedema suspected.
  • Tracheostomy: consider if prolonged ventilation anticipated, difficult wean, heavy secretion burden, or need for ongoing airway protection; balance against procedural risk.

Predictors/indices (useful but not definitive)

  • RSBI (rapid shallow breathing index) = f/VT (breaths/min divided by litres).
    • RSBI < 105 often associated with weaning success, but performance varies; interpret in context.
  • Respiratory muscle strength: NIF/MIP more negative than about −20 to −30 cmH2O suggests adequate strength (context-dependent).
  • Vital capacity (older metric): >10–15 mL/kg sometimes quoted; limited ICU utility.
  • Cuff leak test: assesses risk of post-extubation laryngeal oedema/stridor (not a test of readiness to breathe).

Extubation readiness: a structured approach

  • 1) Can they breathe? (ventilation/oxygenation likely to be sustained off the ventilator)
    • Successful SBT without distress: stable RR, acceptable gas exchange, no marked tachycardia/HTN, no diaphoresis or agitation.
  • 2) Can they protect their airway? (conscious level, cough, swallow, secretion burden)
    • Assess: cough on suction/catheter, ability to manage secretions, gag not required.
  • 3) Is the upper airway patent? (laryngeal oedema, obstruction risk)
    • Risk factors for oedema: prolonged intubation, traumatic intubation, large tube, female, high cuff pressures, airway surgery, prone positioning, fluid overload.
    • If high risk: cuff leak test, consider steroids (e.g., dexamethasone) pre-extubation per local policy; plan for stridor management.
  • 4) Is there a plan if it fails? (re-intubation strategy, equipment, skilled help, ceiling of care)

High-risk extubation (ICU and theatre): identification and planning

  • High-risk features:
    • Difficult re-intubation predicted/known (airway pathology, limited mouth opening/neck movement, obesity, previous difficult intubation).
    • High risk of obstruction: airway oedema, head/neck surgery, airway burns, OSA, haematoma risk.
    • High risk of respiratory failure: COPD, heart failure, neuromuscular weakness, high secretion load, poor cough, borderline gas exchange, prolonged ventilation.
  • Planning options:
    • Extubate fully awake where appropriate; ensure full reversal of neuromuscular blockade (quantitative TOF).
    • Staged extubation with airway exchange catheter (AEC) left in situ for rapid re-intubation; oxygen insufflation via AEC only with caution and appropriate technique due to barotrauma risk.
    • Extubate to HFNO or NIV (particularly COPD, obesity hypoventilation, cardiogenic pulmonary oedema, post-op high-risk).
    • Delay extubation / consider tracheostomy if airway patency or protection is doubtful.

Practical extubation sequence (ICU/theatre)

  • Preparation: suction oral + ETT, sit up, pre-oxygenate, ensure monitoring, check cuff pressure history, confirm plan and re-intubation kit readiness.
  • Optimise: analgesia, antiemetic, bronchodilator if wheezy, treat fluid overload, ensure normothermia.
  • Reversal: ensure no residual paralysis (quantitative TOF ratio ≥ 0.9).
  • Extubation: deflate cuff, remove at end-inspiration (common practice), apply oxygen, encourage cough, clear secretions.
  • Post-extubation: continuous observation, early ABG if concern, chest physio, humidification, consider HFNO/NIV, manage pain and delirium.

Post-extubation complications and management

  • Upper airway obstruction/stridor (laryngeal oedema):
    • Immediate: high-flow oxygen, sit up, nebulised adrenaline, IV dexamethasone (if not already), consider heliox where available, call for help early.
    • If worsening/impending obstruction: early re-intubation (do not persist with temporising measures).
  • Laryngospasm (more theatre than ICU): jaw thrust, CPAP with 100% O2, deepen anaesthesia, consider small-dose propofol; if persistent, suxamethonium and intubate/ventilate.
  • Respiratory failure (hypoxaemia/hypercapnia): treat cause (atelectasis, bronchospasm, pulmonary oedema, pneumonia, PE, opioid excess). Use HFNO/NIV when appropriate; re-intubate early if failing.
  • Aspiration: suction, oxygen, consider bronchoscopy if particulate, antibiotics only if infection suspected (not routine), re-intubate if needed.
  • Negative pressure pulmonary oedema (post-obstruction): oxygen, CPAP/PEEP, diuretics if appropriate, consider re-intubation/ventilation.
  • Haemodynamic instability/ischaemia during wean/extubation: treat pain/anxiety, optimise preload/afterload, consider echo, diuresis/vasodilators/inotropes as indicated.

Extubation in selected groups (high-yield)

  • COPD/CO2 retainers:
    • Accept permissive hypercapnia if pH acceptable; extubate to NIV if high risk; avoid excessive oxygen (target saturations per patient).
  • Obesity/OSA:
    • Head-up positioning, extubate fully awake, consider CPAP/NIV, aggressive atelectasis prevention (PEEP, recruitment, early mobilisation).
  • Neuromuscular disease/weakness:
    • High risk of failure due to weak cough/secretions; consider NIV, cough assist, and lower threshold for tracheostomy if prolonged.
  • Head/neck surgery or airway oedema risk:
    • Consider delayed extubation, cuff leak assessment, steroids, AEC/staged extubation; ensure immediate access to re-intubation and surgical airway expertise.
You are asked to review an ICU patient for extubation. How do you assess readiness and what is your plan?

Structure: (1) readiness to wean (2) SBT (3) airway protection/patency (4) extubation plan and failure plan.

  • Confirm indication improving + no new instability; review ventilator settings and trends (FiO2, PEEP, pressures, compliance).
  • Check oxygenation/ventilation: acceptable SpO2 on FiO2 ≤0.4–0.5 and PEEP ≤5–8; acceptable pH/PaCO2 for patient.
  • Haemodynamics: minimal vasopressors, no active ischaemia/arrhythmia; consider fluid status and heart failure.
  • Neurology: awake enough, follows commands, cough present; sedation plan (SAT) and delirium management.
  • Secretions: frequency of suction, quality of cough, chest physio needs; consider CXR/ultrasound if concerns.
  • Perform/confirm SBT (30–120 min) using T-piece/CPAP/low PS; monitor RR, VT, accessory muscle use, HR/BP, SpO2, comfort.
  • Airway patency risk: prolonged intubation/trauma/head-neck surgery; consider cuff leak test and pre-extubation steroids if high risk.
  • Extubation plan: position head-up, suction, pre-oxygenate; extubate to oxygen/HFNO/NIV depending on risk; ensure senior help and re-intubation kit ready.
Describe how you would conduct a spontaneous breathing trial. What constitutes failure?

SBT assesses ability to sustain spontaneous breathing with minimal support; it is not a guarantee of extubation success.

  • Method: T-piece, CPAP, or low PS (e.g., PS 5–8 with PEEP 5); duration commonly 30–120 min.
  • Monitor: RR/VT pattern, accessory muscle use, dyspnoea, SpO2, ETCO2/ABG if needed, HR/BP, arrhythmias, agitation/diaphoresis.
  • Failure features: sustained tachypnoea, hypoxaemia, rising CO2 with acidaemia, tachycardia/arrhythmia, marked hypertension/hypotension, distress, reduced consciousness.
  • If fail: return to support, identify reversible causes (fluid overload, bronchospasm, infection, pain/anxiety, electrolyte issues, cardiac dysfunction).
What is the rapid shallow breathing index (RSBI)? How do you use it and what are its limitations?

RSBI is a screening tool; do not use in isolation.

  • Definition: RSBI = respiratory frequency (breaths/min) divided by tidal volume (L).
  • Interpretation: RSBI < 105 is often associated with weaning success; higher values suggest rapid shallow breathing and likely failure.
  • Limitations: affected by ventilator settings, anxiety/pain, fever, metabolic acidosis; poor specificity; does not assess airway protection/patency.
A patient develops stridor 10 minutes after extubation. How do you manage this?

Assume laryngeal oedema until proven otherwise; act early and have a low threshold to re-intubate.

  • Call for help; sit patient up; high-flow oxygen; continuous monitoring.
  • Nebulised adrenaline; IV dexamethasone (if not already given); consider humidified oxygen/heliox if available.
  • Assess severity: work of breathing, voice, SpO2, fatigue, reduced consciousness.
  • If severe or deteriorating: early re-intubation with experienced operator; prepare for difficult airway and possible front-of-neck access.
  • After stabilisation: review risk factors (tube size, cuff pressure, duration), document and plan future extubation strategy (e.g., AEC, steroids).
How do you assess the risk of post-extubation laryngeal oedema and what is the role of the cuff leak test?

Cuff leak helps identify reduced laryngeal lumen; it is imperfect and should be combined with clinical risk assessment.

  • Risk factors: prolonged intubation, traumatic intubation, large ETT, female, high cuff pressures, airway surgery, prone positioning, fluid overload.
  • Cuff leak test: deflate cuff and assess leak volume/audible leak; absent/small leak suggests higher risk of oedema/stridor.
  • Limitations: false positives/negatives; affected by secretions, tube position, ventilator settings; does not guarantee safety.
  • If high risk: consider pre-extubation steroids (timed doses), staged extubation/AEC, and ensure immediate re-intubation capability.
Explain weaning-induced pulmonary oedema. How would you recognise and treat it?

Transition to spontaneous breathing increases LV afterload and venous return; susceptible patients may develop pulmonary oedema during SBT.

  • Mechanism: more negative intrathoracic pressure → ↑ venous return and ↑ LV transmural pressure (afterload) → LV failure/pulmonary congestion; sympathetic surge may contribute.
  • Recognition: SBT failure with tachypnoea, hypoxaemia, hypertension, frothy secretions, new crackles; rising BNP; echo/ultrasound supportive (B-lines, LV dysfunction).
  • Treatment: return to ventilatory support with PEEP/CPAP; diuresis; vasodilators if hypertensive; treat ischaemia; consider NIV post-extubation if appropriate.
Describe a high-risk extubation strategy for a patient with a known difficult airway.

Goal: maintain ability to oxygenate and facilitate rapid re-intubation if needed.

  • Plan and team: senior anaesthetist, difficult airway trolley, ENT/FONA readiness if indicated; agree triggers for re-intubation.
  • Optimise conditions: full reversal (TOF ≥0.9), normothermia, adequate analgesia, minimal secretions, head-up position, pre-oxygenation.
  • Consider staged extubation with an airway exchange catheter left in situ; confirm tolerance and secure it; avoid high-pressure jetting due to barotrauma risk.
  • Extubate awake where appropriate; consider extubation to HFNO/CPAP to maintain oxygenation and reduce atelectasis.
  • Post-extubation: close monitoring in appropriate area; keep AEC until confident; document airway and extubation course.
A patient fails extubation and becomes hypercapnic with reduced consciousness. What are your immediate actions and differential diagnosis?

Treat as impending respiratory arrest: support ventilation and decide early on re-intubation.

  • Immediate: airway opening manoeuvres, high-flow oxygen, assist ventilation with bag-mask; call for help; prepare for re-intubation.
  • Consider NIV only if cooperative, protecting airway, and problem is ventilatory failure without immediate airway threat; otherwise intubate.
  • Differential: residual neuromuscular blockade, opioid/sedative excess, COPD exacerbation/bronchospasm, fatigue, pulmonary oedema, atelectasis, pneumonia, PE, metabolic acidosis driving fatigue.
  • Targeted checks: TOF, pupils/sedation review, ABG, chest exam, CXR/US, ECG/troponin if ischaemia suspected.
Discuss the role of sedation management in weaning from mechanical ventilation.

Over-sedation delays weaning; under-sedation causes agitation, dyssynchrony, and failure. Protocols improve outcomes.

  • Daily sedation interruption (SAT) paired with SBT reduces ventilator days and ICU length of stay.
  • Aim for light sedation where appropriate (e.g., RASS target), treat pain first (analgosedation concept).
  • Avoid residual drug effects at extubation: long-acting opioids/benzodiazepines can cause hypoventilation and delirium.
  • Manage delirium: reorientation, sleep hygiene, minimise deliriogenic drugs; consider dexmedetomidine where appropriate to facilitate extubation in selected patients.
How do you decide between extubation, delayed extubation, and tracheostomy in a prolonged ventilated patient?

Decision balances likelihood of early liberation vs risks of repeated extubation failure and airway/ventilator complications.

  • Extubate if: SBT success + airway protection/patency likely + manageable secretions + clear failure plan.
  • Delay extubation if: airway oedema risk, borderline gas exchange, ongoing procedures, fluctuating consciousness, heavy secretions without adequate cough.
  • Consider tracheostomy if: prolonged ventilation expected, repeated SBT failure, need for prolonged airway protection, secretion management issues, facilitation of rehab/weaning.
  • Also consider patient goals/ceiling of care and likelihood of meaningful recovery.
List common reversible causes of weaning failure.
  • Fluid overload/heart failure, myocardial ischaemia, bronchospasm, pneumonia/sepsis, atelectasis, pulmonary embolism.
  • Pain, anxiety, delirium; over-sedation; opioid excess.
  • Electrolyte issues (↓PO4, ↓Mg, ↓K), anaemia, fever, malnutrition.
  • Excess secretions, weak cough, upper airway obstruction.
Give key differences between 'can they breathe?' and 'can they protect their airway?' in extubation assessment.
  • Breathe: gas exchange + respiratory mechanics (SBT success, oxygenation/ventilation, fatigue).
  • Protect airway: consciousness, cough, secretion handling, aspiration risk, bulbar function.
  • Upper airway patency is separate: laryngeal oedema/obstruction risk (cuff leak, risk factors).

0 comments